DEVELOPMENT OF MONOTHIOL HUMAN THIOREDOXIN-1 (ORP100S) AS AN INHALED TREATMENT FOR ACUTE VIRAL LUNG INJURY

$2,147,023FY2022Defense Health AgencyDOD

Orpro Therapeutics Inc

Investigators